We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The National Pharmaceutical Pricing Authority has requested the CDSCO to provide the details of manufacture of cardiac and anti-diabetic drugs especially in respect of insulin, aspirin and atorvastatin.